Clinical trials are an essential step to transform laboratory research into viable cancer treatments. Trials are where today’s care drives future progress, transforming research breakthroughs into accessible, life-extending options for individuals facing cancer.

But for most pancreatic cancer patients, clinical trial options are limited. The process is too complex, too overwhelming, and too slow to make a meaningful difference when time matters most.

Pancreatic Cancer Canada is leading the charge towards more accessible and equitable access to clinical trials.

We are a proud member of CanReview, a national initiative striving to make clinical trials more accessible for Canadians. CanReview simplifies one of the early challenges in launching clinical trials by enabling a single, streamlined ethics review for studies happening in multiple provinces.

By streamlining review processes, researchers and trials will start faster, including in underserved, rural or remote communities, and will make Canada a more attractive and sought after country to conduct global research.

‍

‍